Invention Grant
- Patent Title: Temozolomide powder formulation
-
Application No.: US15923852Application Date: 2018-03-16
-
Publication No.: US10555943B2Publication Date: 2020-02-11
- Inventor: Gary Payton , Jeff Bryant
- Applicant: AmpliPharm Pharmaceuticals, LLC
- Applicant Address: US GA Johns Creek
- Assignee: AMPLIPHARM PHARMACEUTICALS, LLC
- Current Assignee: AMPLIPHARM PHARMACEUTICALS, LLC
- Current Assignee Address: US GA Johns Creek
- Agency: Blank Rome LLP
- Main IPC: A61K31/495
- IPC: A61K31/495 ; A61K9/00 ; A61K9/16 ; A61K47/14 ; A61K31/4188 ; A61K47/02 ; A61K47/10

Abstract:
The present invention relates to a solid pharmaceutical composition of temozolomide that has good and consistent flowability as a powder and taste masking and is readily dispersible in an aqueous solution suitable for oral administration, e.g., as a dry sprinkle. This permits patients and healthcare workers to accurately measure doses and safely dispense the drug.
Public/Granted literature
- US20180200249A1 TEMOZOLOMIDE POWDER FORMULATION Public/Granted day:2018-07-19
Information query